190 related articles for article (PubMed ID: 17970044)
1. Expression of S100 protein family members in the pathogenesis of bladder tumors.
Yao R; Lopez-Beltran A; Maclennan GT; Montironi R; Eble JN; Cheng L
Anticancer Res; 2007; 27(5A):3051-8. PubMed ID: 17970044
[TBL] [Abstract][Full Text] [Related]
2. S100-mediated signal transduction in the nervous system and neurological diseases.
Zimmer DB; Chaplin J; Baldwin A; Rast M
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(2):201-14. PubMed ID: 16171556
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of S100 gene family in human esophageal squamous cell carcinoma.
Ji J; Zhao L; Wang X; Zhou C; Ding F; Su L; Zhang C; Mao X; Wu M; Liu Z
J Cancer Res Clin Oncol; 2004 Aug; 130(8):480-6. PubMed ID: 15185146
[TBL] [Abstract][Full Text] [Related]
4. Identification of genes correlated with early-stage bladder cancer progression.
Stone R; Sabichi AL; Gill J; Lee IL; Adegboyega P; Dai MS; Loganantharaj R; Trutschl M; Cvek U; Clifford JL
Cancer Prev Res (Phila); 2010 Jun; 3(6):776-86. PubMed ID: 20501863
[TBL] [Abstract][Full Text] [Related]
5. In silico analysis and verification of S100 gene expression in gastric cancer.
Liu J; Li X; Dong GL; Zhang HW; Chen DL; Du JJ; Zheng JY; Li JP; Wang WZ
BMC Cancer; 2008 Sep; 8():261. PubMed ID: 18793447
[TBL] [Abstract][Full Text] [Related]
6. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Grubbs CJ; Lubet RA; Koki AT; Leahy KM; Masferrer JL; Steele VE; Kelloff GJ; Hill DL; Seibert K
Cancer Res; 2000 Oct; 60(20):5599-602. PubMed ID: 11059745
[TBL] [Abstract][Full Text] [Related]
7. Reduced expression of the CDK inhibitor p27(KIP1) in rat two-stage bladder carcinogenesis and its association with expression profiles of p21(WAF1/Cip1) and p53.
Lee CC; Ichihara T; Yamamoto S; Wanibuchi H; Sugimura K; Wada S; Kishimoto T; Fukushima S
Carcinogenesis; 1999 Sep; 20(9):1697-708. PubMed ID: 10469613
[TBL] [Abstract][Full Text] [Related]
8. Alterations of beta- and gamma-catenin in N-butyl-N-(-4-hydroxybutyl)nitrosamine-induced murine bladder cancer.
Shiina H; Igawa M; Urakami S; Shigeno K; Yoneda T; Terashima M; Deguchi M; Ribeiro-Filho L; Dahiya R
Cancer Res; 2001 Oct; 61(19):7101-9. PubMed ID: 11585741
[TBL] [Abstract][Full Text] [Related]
9. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
[TBL] [Abstract][Full Text] [Related]
10. Expression profile of the S100 gene family members in oral squamous cell carcinomas.
Sapkota D; Bruland O; Bøe OE; Bakeer H; Elgindi OA; Vasstrand EN; Ibrahim SO
J Oral Pathol Med; 2008 Nov; 37(10):607-15. PubMed ID: 18705642
[TBL] [Abstract][Full Text] [Related]
11. Multifarious diagnostic possibilities of the S100 protein family: predominantly in pediatrics and neonatology.
Medkova A; Srovnal J; Potomkova J; Volejnikova J; Mihal V
World J Pediatr; 2018 Aug; 14(4):315-321. PubMed ID: 29858979
[TBL] [Abstract][Full Text] [Related]
12. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
13. The S100 proteins for screening and prognostic grading of bladder cancer.
Yao R; Davidson DD; Lopez-Beltran A; MacLennan GT; Montironi R; Cheng L
Histol Histopathol; 2007 Sep; 22(9):1025-32. PubMed ID: 17523080
[TBL] [Abstract][Full Text] [Related]
14. Identification of differently expressed genes in chemical carcinogen-induced rat bladder cancers.
Chen G; Chan FL; Zhang X; Chan PS
J Huazhong Univ Sci Technolog Med Sci; 2009 Apr; 29(2):220-6. PubMed ID: 19399409
[TBL] [Abstract][Full Text] [Related]
15. Modulation of gene expression and cell-cycle signaling pathways by the EGFR inhibitor gefitinib (Iressa) in rat urinary bladder cancer.
Lu Y; Liu P; Van den Bergh F; Zellmer V; James M; Wen W; Grubbs CJ; Lubet RA; You M
Cancer Prev Res (Phila); 2012 Feb; 5(2):248-59. PubMed ID: 21982874
[TBL] [Abstract][Full Text] [Related]
16. Expression of members of the S100 Ca2+-binding protein family in guinea-pig smooth muscle.
Daub B; Schroeter M; Pfitzer G; Ganitkevich V
Cell Calcium; 2003 Jan; 33(1):1-10. PubMed ID: 12526882
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analysis of the expression and prognosis for S100 in human ovarian cancer: A STROBE study.
Xu HY; Song HM; Zhou Q
Medicine (Baltimore); 2020 Nov; 99(47):e22777. PubMed ID: 33217795
[TBL] [Abstract][Full Text] [Related]
18. Clustered organization of S100 genes in human and mouse.
Ridinger K; Ilg EC; Niggli FK; Heizmann CW; Schäfer BW
Biochim Biophys Acta; 1998 Dec; 1448(2):254-63. PubMed ID: 9920416
[TBL] [Abstract][Full Text] [Related]
19. Identifying superficial, muscle-invasive, and metastasizing transitional cell carcinoma of the bladder: use of cDNA array analysis of gene expression profiles.
Modlich O; Prisack HB; Pitschke G; Ramp U; Ackermann R; Bojar H; Vögeli TA; Grimm MO
Clin Cancer Res; 2004 May; 10(10):3410-21. PubMed ID: 15161696
[TBL] [Abstract][Full Text] [Related]
20. S100 proteins in the epidermis.
Eckert RL; Broome AM; Ruse M; Robinson N; Ryan D; Lee K
J Invest Dermatol; 2004 Jul; 123(1):23-33. PubMed ID: 15191538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
